Molotinib

药品简介

Originator: OJJAARA by GLAXOSMITHKLINE · Manufacturer: TLPH Pharma. Indication & Dosage: Molotinib (Momelotinib), generic OJJAARA is a prescription medicine used to treat treatment of intermediate to high-risk myelofibrosis (MF) in adults with anemia. This includes primary myelofibrosis (PMF) as well as secondary myelofibrosis arising from post-polycythemia vera (PV) or post-essential thrombocythemia (ET). Molotinib manufactured by TLPH Pharma Ltd. in Laos. Momelotinib has to take orally once a daily with or without food as directed by patients doctor. Side Effects: The most common side effects of Momelotinib are: Thrombocytopenia (low platelet counts), Hemorrhage (bleeding), Bacterial infections, Fatigue, Dizziness, Diarrhea, Nausea. The above information comes from the Internet. Please consult with doctor for medical advice.

本信息仅供参考，不构成医疗建议。请务必咨询合格的医疗专业人士。